J.‐P. Bronowicki

1.1k citations

31 papers · 731 indexed · h-index 15

Impact in

Hepatology top 1%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 21
- Hepatitis C virus research 18
- Hepatocellular Carcinoma Treatment and Prognosis 2
Genetics 7
- Chronic Lymphocytic Leukemia Research 7
- Diabetes and associated disorders 2

Co-authors: Laurent Peyrin‐Biroulet Alexander C. Ford Emmanuel Gizard Marc Bourlière Lucy Dagher Stephanie Heldner J.F. Geschwind Seung Kew Yoon
Journals: Journal of Hepatology (17 papers)Alimentary Pharmacology & Therapeutics (4 papers)Journal of Viral Hepatitis (1 paper)Clinical & Experimental Allergy (1 paper)Journal of Internal Medicine (1 paper)
Partner nations: France United States Germany

In The Last Decade

J.‐P. Bronowicki

30 papers receiving 712 citations

Peers

Countries citing papers authored by J.‐P. Bronowicki

Since Specialization

Citations

This map shows the geographic impact of J.‐P. Bronowicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐P. Bronowicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐P. Bronowicki more than expected).

Fields of papers citing papers by J.‐P. Bronowicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐P. Bronowicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐P. Bronowicki. The network helps show where J.‐P. Bronowicki may publish in the future.

Co-authors

The 25 scholars most cited alongside J.‐P. Bronowicki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.‐P. Bronowicki Line = papers co-authored together J.‐P. Bronowicki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	RNA editing blood biomarkers for predicting mood alterations in HCV patients Journal of NeuroVirology ·Nicolas Salvetat, Siem van der Laan, Bérengère Vire, Fabrice Chimienti, 韩丽涛, J.‐P. Bronowicki, M Doffoël, Marc Bourlière, Raymund Schwan, Jian‐Ping Lang, Jean‐François Pujol, Dinah Weissmann	2019	10
2	P0376 : Stratification of hepatocellular carcinoma. The prognostic score NIACE, an additional aid to the Barcelona Clinic Liver Cancer (BCLC) staging system? Multicenter study Journal of Hepatology ·Xavier Adhoute, Guillaume Pénaranda, J.F. Blanc, Julien Edeline, 汉城, Hervé Perrier, O. Monnet, Patrizia Castellani, Valérie Oulès, Olivier Bayle, Guillaume Conroy, Ho, H. Benzaquen Forner, Bernard Pol, J.‐P. Bronowicki, Jean‐Luc Raoul, Marc Bourlière	2015	1
3	1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 OR -4 CHRONIC HEPATITIS C: SVR24 RESULTS FROM A RANDOMIZED PHASE 2B STUDY (AI447016) Journal of Hepatology ·J.‐P. Bronowicki, Vlad Ratziu, Adrián Gadano, Paul J. Thuluvath, Fernando Bessone, Claudia Martorell, Stanislas Pol, Rubén Terg, Ziad Younes, Bing He, Timothy Eley, David Cohen, Patricia Méndez, Eric Hughes	2013	10
4	Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin Alimentary Pharmacology & Therapeutics ·Stuart C. Gordon, Eric M. Yoshida, Eric Lawitz, Bruce R. Bacon, Mark Sulkowski, Mitchell Davis, Fred Poordad, J.‐P. Bronowicki, Rafael Esteban, Vilma Sniukiene, Margaret Burroughs, Weiping Deng, Frank J. Dutko, Clifford A. Brass, Janice K. Albrecht, K. Rajender Reddy	2013	17
5	1430 SAFETY AND EFFICACY OF BOCEPREVIR/PEGINTERFERON/ RIBAVIRIN (BOC/P/R) COMBINATION THERAPY FOR CHRONIC HCV G1 PATIENTS WITH COMPENSATED CIRRHOSIS: A META-ANALYSIS OF FIVE PHASE 3 CLINICAL TRIALS Journal of Hepatology ·Anne Paquet, Stefan Zeuzem, F. Poordad, J.‐P. Bronowicki, M.P. Manns, B. Bacon, Rafael Esteban, S. Flamm, Paul Y. Kwo, Lisa D. Pedicone, Wenjun Deng, Frank J. Dutko, Mark J. DiNubile, Kenneth Koury, F.A. Helmond, Janice Wahl, Savino Bruno	2013	8
6	1094 100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL Journal of Hepatology ·J.‐P. Bronowicki, Christophe Hézode, Leif Bengtsson, S. Pol, Marc Bourlière, Lawrence Serfaty, Victor de Lédinghen, Albert Tran, Y. Benhamou, Herbert Hüttlin, Philippe Mathurin, Patrick Marcellin, Christian Trépo, Jean‐Pierre Zarski, Alessandra Faggion Mocellin, Kevin R. Kelliher, Martyn C. Botfield, Jean–Michel Pawlotsky	2012	34
7	101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2 Journal of Hepatology ·Stefan Zeuzem, Vincent Soriano, Tarik Asselah, J.‐P. Bronowicki, Ansgar W. Lohse, Beat Müllhaupt, M. Schuchmann, Marc Bourlière, Marı́a Buti, Stuart K. Roberts, Edward Gane, Jerry O. Stern, George Kukolj, Lili Dai, W.O. Böcher, Federico Mensa	2012	53
8	66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R Journal of Hepatology ·Mark Sulkowski, Marc Bourlière, J.‐P. Bronowicki, Adrian Streinu‐Cercel, Liliana Preoțescu, Tarik Asselah, Jean–Michel Pawlotsky, Stephen D. Shafran, Stanislas Pol, Florin Alexandru Căruntu, A. Saakes, Dominique Larrey, Charles D. Hafner, Yakov Datsenko, Jerry O. Stern, Robert Kubiak, W.O. Böcher, Gerhard Steinmann	2011	25
9	Maladie de Wilson chez l’adulte La Revue de Médecine Interne ·Suthin Khankhua, J.‐P. Bronowicki, Yuris Martinez, Alexis Jacquier, P. Kaminsky	2011	4
10	81 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB) STUDY FIRST INTERIM RESULTS: SORAFENIB DOSING ACROSS REGIONS AND DISEASE SUBGROUPS Journal of Hepatology ·J.‐P. Bronowicki, Riccardo Lencioni, Alan P. Venook, Jorge A. Marrero, Masatoshi Kudo, B.R. Roth, Keiko Nakajima, Frank Cihon, Christos N. Papandreou	2011	2
11	Inflammatory bowel disease and hepatitis B and C Gastroentérologie Clinique et Biologique ·R C Ramdev, Marc‐André Bigard, Mouni Bensenane, Abderrahim Oussalah, László Bejó, Arthur Belle, Oliva Priego E, J.‐P. Bronowicki, Laurent Peyrin‐Biroulet	2009	20
12	Maladies inflammatoires chroniques intestinales et hépatites B et C Gastroentérologie Clinique et Biologique ·R C Ramdev, Marc‐André Bigard, Mouni Bensenane, Abderrahim Oussalah, László Bejó, Arthur Belle, Oliva Priego E, J.‐P. Bronowicki, Laurent Peyrin‐Biroulet	2009	0
13	123 EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL Journal of Hepatology ·C. Hézode, Juliette Foucher, J.‐P. Bronowicki, Valériane Leroy, Albert Tran, Dominique Larrey, Philippe Mathurin, Isabelle Rosa, Laurent Alric, Valérie Dhalluin-Venier, Oliva Priego E, Magali Bouvier‐Alias, Stéphanie Rouanet, Patrice Couzigou, Mariano Gonzalez Pisfil, George R. Goodall, Jean–Michel Pawlotsky	2009	1
14	Peut-on arrêter un traitement par analogue nucléos(t)idique chez un malade atteint d’hépatite chronique B ? Gastroentérologie Clinique et Biologique ·J.‐P. Bronowicki, Oliva Priego E, Hélène Barraud, Battula Bhavyasree	2008	1
15	Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression Alimentary Pharmacology & Therapeutics ·Laurent Peyrin‐Biroulet, Rohmat Hidayah, Renghan Dong, Abderrahim Oussalah, Mimouna Seddik, V. Canva, Antoine Cortot, Philippe Sogni, Jean‐Louis Guéant, Marc‐André Bigard, Xavier Roblin, J.‐P. Bronowicki	2008	25
16	Hépatite C : quelle stratégie en cas d’échec thérapeutique ? Gastroentérologie Clinique et Biologique ·J.‐P. Bronowicki, Dominique Larrey, Albert Tran, C. Perronne, Jacques Denis, Jean–François Cadranel, C. Trépo	2008	2
17	58 TREATMENT OF CHRONIC HEPATITIS C WITH TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON-ALFA-2A WITH OR WITHOUT RIBAVIRIN: FURTHER INTERIM ANALYSIS RESULTS OF THE PROVE2 STUDY Journal of Hepatology ·Neil Gehlres, Christophe Hézode, Stanislas Pol, Tobias Goeser, J.‐P. Bronowicki, Marc Bourlière, Peter Buggisch, Lawrence Serfaty, Thomas Berg, Maribel Contreras Contreras, Y. Benhamou, Nicole Forestier, Leif Bengtsson, Shahin Gharakhanian, R. G. Kauffman, Junaid Alam, Péter Ferenci, Jean–Michel Pawlotsky, Stefan Zeuzem	2008	34
18	[613] VIROLOGICAL RESPONSE AT 4 AND 12 WEEKS PREDICT HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN GENOTYPE 1 PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) PLUS RIBAVIRIN Journal of Hepatology ·Patrick Marcellin, S. Hadziyannis, Thomas Berg, Vivian Arias Vallejo, J.‐P. Bronowicki, Toshitaka Sakai, Amy Lin, Andreas Tietz, Péter Ferenci	2007	10
19	Peginterferon alpha‐2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha‐2b Journal of Viral Hepatitis ·Armand Abergel, Christophe Hézode, Vincent Leroy, Karl Barange, J.‐P. Bronowicki, Albert Tran, Laurent Alric, Laurent Castéra, P. Bernard, Cécile Henquell, H. Lafeuille, Sylvie Ughetto, Claude Darcha, M. Chevallier, Tränkeweg, Dahir Abshir Fara, C E Looney, Daniel Dhumeaux, Gilles Bommelaer, Christophe Bonny	2006	36
20	Cobalamin deficiency with megaloblastic anaemia in one patient under long‐term omeprazole therapy Journal of Internal Medicine ·Abdelouahab Bellou, Isabelle Aimone‐Gastin, Arthur L. Zemanek, J.‐P. Bronowicki, J Petrůj, J. P. Nicolas, Seok-Jun An, J. L. Guéant	1996	34

About J.‐P. Bronowicki

J.‐P. Bronowicki is a scholar working on Hepatology, Genetics, Rheumatology, Epidemiology and Immunology, having authored 31 papers that have together received 731 indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Systemic Lupus Erythematosus Research (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Hepatology (589 citations), Epidemiology (465 citations), Rheumatology (73 citations), Infectious Diseases (81 citations) and Pathology and Forensic Medicine (69 citations). J.‐P. Bronowicki has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Laurent Peyrin‐Biroulet, Alexander C. Ford, Emmanuel Gizard, Marc Bourlière, Lucy Dagher, Stephanie Heldner, J.F. Geschwind, Seung Kew Yoon, Christophe Hézode and Keiko Nakajima. Their work appears in journals such as Journal of Hepatology, Alimentary Pharmacology & Therapeutics, Journal of Viral Hepatitis, Clinical & Experimental Allergy and Journal of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact